Association study of a functional promoter polymorphism in the XBP1 gene and schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 141 B, Issue 1, 2006, Pages 71-75

  Jönsson, Erik G ^a   Cichon, Sven ^b   Schumacher, Johannes ^b   Jamra, Kami Abou ^b   Schulze, Thomas G ^c   Deschner, Monica ^c   Forslund, Kaj ^a   Hall, Håkan ^a   Propping, Peter ^b   Czerski, Piotr M ^d   Dmitrak Weglarz, Monica ^d   Kapelski, Pawel ^d   Driessen, Martin ^e   Maier, Wolfgang ^b   Hauser, Joanna ^d   Rietschel, Marcella ^c   Nöthen, Markus M ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BONN   (Germany)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^e Center of Psychiatry and Psychotherapeutic Medicine   (Germany)

Author keywords

Bipolar disorder; Case control association study; Meta analysis; X box binding protein 1 gene (XBP1)

Indexed keywords

BINDING PROTEIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FUNCTIONAL GENOMICS; GENE; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SWEDEN; XBP1 GENE;

ALLELES; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; MALE; NUCLEAR PROTEINS; POLAND; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA; SWEDEN;

EID: 30344435574     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30262     Document Type: Article

References (22)

1. Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P. 2002. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159:539-545.
2. Chen W, Duan S, Zhou J, Sun Y, Zheng Y, Gu N, Feng G, He L. 2004. A case-control study provides evidence of association for a functional polymorphism -197C/G in XBP1 to schizophrenia and suggests a sex-dependent effect. Biochem Biophys Res Commun 319:866-870.
3. Cichon S, Buervenich S, Kirov G, Akula N, Dimitrova A, Green E, Schumacher J, Klopp N, Becker T, Ohlraun S, et al. 2004. Lack of support for a genetic association of the XBP1 promoter polymorphism with bipolar disorder in probandsof European origin. Nat Genet 36:783-784.
4. Craddock N, O'Donovan MC, Owen MJ. 2005. The genetics of schizophrenia and bipolar disorder: Dissecting psychosis. J Med Genet 42:193-204.
5. Crow TJ. 1990. Nature of the genetic contribution to psychotic illness-A Scontinuum viewpoint. Acta Psychiatr Scand 81:401-408.
6. Ding C, Cantor CR. 2003. Direct molecular haplotyping of long-range genomic DNA with M1-PCR. Proc Natl Acad Sci USA 100:7449-7453.
7. Emery AEH. 1986. Methodology in Medical Genetics. Edinburgh, London, Melbourne and New York: Churchill Livingstone. pp 114-125.
8. Glatt SJ, Faraone SV, Tsuang MT. 2003. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol Psychiatry 8:911-915.
9. Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68.
10. Hou SJ, Yen FC, Cheng CY, Tsai SJ, Hong CJ. 2004. X-box binding protein 1 (XBP1) C-116G polymorphisms in bipolar disorders and age of onset. Neurosci Lett 367:232-234.
11. Jönsson EG, Sillén A, Vares M, Ekholm B, Terenius L, Sedvall GC. 2003. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: Association study and meta-analysis. Am J Med Genet Part B 119B:28-34.
12. Jönsson EG, Kaiser R, Brockmöller J, Nimgaonkar VL, Crocq M-A. 2004. Meta-analysis of dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet 14:9-12.
13. Kahn HA, Sempos CT. 1989. Statistical methods in epidemiology. New York, Oxford: Oxford University Press, pp 51-116.
14. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, Kusumi I, Tsujita T, Okazaki Y, Nanko S, Kunugi H, et al. 2003. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat Genet 35:171-175.
15. Kakiuchi C, Ishiwata M, Umekage T, Tochigi M, Kohda K, Sasaki T, Kato T. 2004. Association of the XBP1- 116C/G polymorphism with schizophrenia in the Japanese population. Psychiatry Clin Neurosci 58:438-440.
16. Liou HC, Eddy R, Shows T, Lisowska-Grospierre B, Griscelli C, Doyle C, Mannhalter J, Eibl M, Glimcher LH. 1991. An HLA-DR alpha promoter DNA-binding protein is expressed ubiquitously and maps to human chromosomes 22 and 5. Immunogenetics 34:286-292.
17. McGuffin P, Reveley A, Holland A. 1982. Identical triplets: Non-identical psychosis? Br J Psychiatry 140:1-6.
18. McGuffin P, Owen MJ, Gottesman II, editors. 2002. Psychiatric genetics & genomics. Oxford: Oxford University Press. 492p.
19. Riley BP, McGuffin P. 2000. Linkage and associated studies of schizophrenia. Am J Med Genet 97:23-44.
20. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C, Evans HJ. 1990. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336:13-16.
21. Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, Becker T, Freudenberg J, Jönsson EG, Mattila-Evenden M, et al. 2003. The DTNBP1 (dysbindin) gene contributes to schizophrenia depending on family history of the disease. Am J Hum Genet 73:1438-1443.
22. Woolf B. 1955. On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.